Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Smallpox - Overview
Smallpox - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Smallpox - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Smallpox - Companies Involved in Therapeutics Development
AlphaVax Inc
Bavarian Nordic A/S
BioFactura Inc
Chimerix Inc
EpiVax Inc
HK inno.N Corp
Polyrizon Ltd
SIGA Technologies Inc
Tonix Pharmaceuticals Holding Corp
Viraze
Smallpox - Drug Profiles
brincidofovir - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CJ-40011 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibody for Smallpox - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NIOCH-14 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PL-801 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
smallpox and monkeypox [ankara] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
smallpox vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
smallpox vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
smallpox vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tecovirimat - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TNX-1200 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TNX-801 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VIR-002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Smallpox - Dormant Projects
Smallpox - Discontinued Products
Smallpox - Product Development Milestones
Featured News & Press Releases
Jan 13, 2021: SIGA Announces Public Health Agency of Cada contract award to purchase up to approximately $33 million of oral TPOXX
Jan 05, 2021: Bavarian Nordic to supply smallpox vaccines to three European countries
Dec 16, 2020: Bavarian Nordic secures second part of Smallpox Vaccine order from the U.S. Government
Dec 07, 2020: Chimerix announces FDA acceptance of New Drug Application for brincidofovir as a medical countermeasure for smallpox
Dec 04, 2020: Vaccine genome researchers report 99.7% colinear identity between a U.S. civil war era smallpox vaccine and horsepox virus
Nov 12, 2020: SIGA Technologies Chief Scientific Officer to participate at NCT Asia Virtual Conference
Oct 08, 2020: SIGA announces Public Health Agency of Cada intent to purchase up to 33,300 courses of Oral TPOXX
Aug 24, 2020: Bavarian Nordic announces positive topline results from Phase 3 Clinical Study of Freeze-dried Smallpox Vaccine
Jul 30, 2020: SIGA announces marketing authorization filing for oral tecovirimat with the European Medicines Agency for multiple indications
Jun 25, 2020: SIGA announces deliveries of oral TPOXX to HHS valued at approximately $32 million
Jun 15, 2020: SIGA Technologies announces Department of Defense increases funding to develop Post-Exposure Prophylactic indication for TPOXX
Jun 01, 2020: SIGA Technologies announces first intertiol delivery of oral TPOXX?
Apr 30, 2020: Bavarian Nordic announces a new order for JYNNEOS Smallpox Vaccine from the U.S. Government potentially worth USD 200 million
Apr 29, 2020: SIGA announces BARDA exercise of contract options valued at $101.3 million for the procurement of oral TPOXX
Apr 28, 2020: Chimerix receives FDA Clearance for rolling submission of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Smallpox, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021


List of Tables


Number of Products under Development for Smallpox, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Smallpox - Pipeline by AlphaVax Inc, 2021
Smallpox - Pipeline by Bavarian Nordic A/S, 2021
Smallpox - Pipeline by BioFactura Inc, 2021
Smallpox - Pipeline by Chimerix Inc, 2021
Smallpox - Pipeline by EpiVax Inc, 2021
Smallpox - Pipeline by HK inno.N Corp, 2021
Smallpox - Pipeline by Polyrizon Ltd, 2021
Smallpox - Pipeline by SIGA Technologies Inc, 2021
Smallpox - Pipeline by Tonix Pharmaceuticals Holding Corp, 2021
Smallpox - Pipeline by Viraze, 2021
Smallpox - Dormant Projects, 2021
Smallpox - Dormant Projects, 2021 (Contd..1)
Smallpox - Discontinued Products, 2021